IDE 1 (CAS 1160927-48-9)

IDE-1, a synthetic compound, has garnered significant attention in scientific research due to its role as a potent activator of the Hedgehog (Hh) signaling pathway. By targeting the smoothened (SMO) receptor, IDE-1 modulates Hh pathway activity, influencing cellular processes such as proliferation, differentiation, and tissue patterning. Its mechanism of action involves binding to the transmembrane protein SMO, leading to conformational changes that activate downstream signaling cascades, including the Gli family of transcription factors. IDE-1′s ability to activate the Hh pathway has been instrumental in elucidating its role in embryonic development, tissue regeneration, and stem cell maintenance. Research employing IDE-1 has provided insights into the molecular mechanisms underlying Hh pathway regulation and its implications in various developmental processes. Additionally, IDE-1 has been utilized in preclinical studies to investigate its potential applications in conditions characterized by dysregulated Hh signaling, such as certain cancers and developmental disorders. Furthermore, IDE-1 serves as a valuable tool in probing the signaling networks involved in embryogenesis and tissue homeostasis, contributing to a deeper understanding of cellular signaling dynamics and offering potential targets for further research endeavors.